Ashvini Keshavan

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Journal: Neurology

Published: July 13, 2026

Factors influencing implementation of an Alzheimer's disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains framework.

Factors influencing implementation of an Alzheimer's disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains framework.

Journal: Age and ageing

Published: December 15, 2025

The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET.

The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 09, 2025

Association of Increase in White Matter Hyperintensity Volume With Rate of Hippocampal Atrophy in a Population-Based Study of Aging.

Association of Increase in White Matter Hyperintensity Volume With Rate of Hippocampal Atrophy in a Population-Based Study of Aging.

Journal: Neurology

Published: August 19, 2025

Plasma phosphorylated tau for Alzheimer's disease diagnosis.

Plasma phosphorylated tau for Alzheimer's disease diagnosis.

Journal: The Lancet. Neurology

Published: July 18, 2025

Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature.

Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: July 12, 2025

Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's disease.

Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 05, 2025

Associations between night/shift working and late-life brain health.

Associations between night/shift working and late-life brain health.

Journal: Brain communications

Published: April 15, 2025

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 10, 2025

Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers.

Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 31, 2025

Retention and longitudinal change in Insight 46, an intensive neuroscience sub-study of the 1946 British birth cohort.

Retention and longitudinal change in Insight 46, an intensive neuroscience sub-study of the 1946 British birth cohort.

Journal: BMC research notes

Published: December 04, 2024

The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.

The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 10, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026